DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,901,458 | -19.9% | 96,338 | -22.5% | 0.87% | -21.4% |
| Q2 2023 | $29,841,120 | -4.8% | 124,338 | 0.0% | 1.11% | -10.0% |
| Q1 2023 | $31,338,150 | -5.0% | 124,338 | 0.0% | 1.24% | -12.8% |
| Q4 2022 | $33,001,792 | -46.0% | 124,338 | -47.4% | 1.42% | -47.6% |
| Q3 2022 | $61,095,000 | +0.2% | 236,537 | -1.6% | 2.70% | +7.5% |
| Q2 2022 | $60,956,000 | -27.8% | 240,437 | -16.5% | 2.52% | +0.1% |
| Q1 2022 | $84,431,000 | -10.8% | 287,837 | 0.0% | 2.51% | +5.2% |
| Q4 2021 | $94,701,000 | +5.3% | 287,837 | -2.6% | 2.39% | +0.7% |
| Q3 2021 | $89,943,000 | +10.7% | 295,437 | -2.4% | 2.37% | +10.5% |
| Q2 2021 | $81,216,000 | +19.2% | 302,637 | 0.0% | 2.15% | +17.6% |
| Q1 2021 | $68,118,000 | +1.3% | 302,637 | 0.0% | 1.82% | +3.9% |
| Q4 2020 | $67,228,000 | -0.8% | 302,637 | -3.8% | 1.76% | -12.1% |
| Q3 2020 | $67,751,000 | +16.2% | 314,637 | -4.6% | 2.00% | +4.7% |
| Q2 2020 | $58,290,000 | +27.8% | 329,637 | 0.0% | 1.91% | +4.5% |
| Q1 2020 | $45,625,000 | -1.7% | 329,637 | +9.0% | 1.82% | +13.9% |
| Q4 2019 | $46,428,000 | +9.1% | 302,500 | +2.7% | 1.60% | +2.0% |
| Q3 2019 | $42,549,000 | +34.4% | 294,600 | +33.0% | 1.57% | +32.3% |
| Q2 2019 | $31,657,000 | +13.5% | 221,500 | +4.7% | 1.19% | +3.3% |
| Q1 2019 | $27,893,000 | +34.8% | 211,600 | +5.5% | 1.15% | +11.2% |
| Q4 2018 | $20,686,000 | -2.9% | 200,600 | +2.3% | 1.03% | +13.3% |
| Q3 2018 | $21,297,000 | +12.4% | 196,000 | +2.1% | 0.91% | +4.6% |
| Q2 2018 | $18,947,000 | +0.8% | 192,000 | 0.0% | 0.87% | -3.0% |
| Q1 2018 | $18,799,000 | +5.5% | 192,000 | 0.0% | 0.90% | +6.8% |
| Q4 2017 | $17,821,000 | +8.2% | 192,000 | 0.0% | 0.84% | +8.2% |
| Q3 2017 | $16,470,000 | +1.6% | 192,000 | 0.0% | 0.78% | -2.0% |
| Q2 2017 | $16,203,000 | -1.3% | 192,000 | 0.0% | 0.79% | -5.1% |
| Q1 2017 | $16,422,000 | +10.5% | 192,000 | +0.5% | 0.84% | +4.6% |
| Q4 2016 | $14,867,000 | +1.4% | 191,000 | +2.1% | 0.80% | +3.1% |
| Q3 2016 | $14,659,000 | -22.4% | 187,000 | 0.0% | 0.78% | -25.1% |
| Q2 2016 | $18,887,000 | +6.5% | 187,000 | 0.0% | 1.04% | +4.6% |
| Q1 2016 | $17,739,000 | +2.1% | 187,000 | 0.0% | 0.99% | +4.1% |
| Q4 2015 | $17,369,000 | +9.0% | 187,000 | 0.0% | 0.95% | +5.0% |
| Q3 2015 | $15,934,000 | -0.4% | 187,000 | 0.0% | 0.91% | +7.9% |
| Q2 2015 | $16,005,000 | -4.8% | 187,000 | -5.6% | 0.84% | -3.0% |
| Q1 2015 | $16,810,000 | +14.7% | 198,000 | +15.8% | 0.87% | +9.8% |
| Q4 2014 | $14,656,000 | +18.3% | 171,000 | +4.9% | 0.79% | +17.1% |
| Q3 2014 | $12,385,000 | -24.0% | 163,000 | -21.3% | 0.67% | -22.9% |
| Q2 2014 | $16,297,000 | +5.0% | 207,000 | 0.0% | 0.87% | +3.4% |
| Q1 2014 | $15,525,000 | -5.1% | 207,000 | -2.4% | 0.84% | -5.3% |
| Q4 2013 | $16,366,000 | +11.4% | 212,000 | 0.0% | 0.89% | +4.3% |
| Q3 2013 | $14,696,000 | +17.3% | 212,000 | +7.1% | 0.86% | +12.1% |
| Q2 2013 | $12,533,000 | – | 198,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |